MANY MINDEDMouse Study Targets Bone Loss Pathway in Aging Mice
Chinese researchers published findings in *Advanced Science* showing that selectively silencing the STING gene in macrophages within aging mouse bone marrow preserved bone density. Their mouse studies tracked bone marrow at ages 3, 10, 18, and 24 months, revealing that the cGAS-STING pathway activation increased progressively with age. Macrophages in older mice exhibited higher baseline STING gene expression and greater mitochondrial DNA leakage—a key factor in age-related bone deterioration. When researchers silenced STING specifically in macrophages aged 12–18 months, bone density remained stable while marrow fat cells decreased. This effect was linked to reduced DPP4 protein secretion from fat cells, which normally worsens bone density in aging. The study identifies STING signaling as a critical mediator of bone loss in aging, though it does not yet explain the full mechanism of marrow fat accumulation.
This work offers a potential future pathway for combating age-related osteoporosis in humans. If the STING pathway’s role in bone marrow fat accumulation translates to humans, targeted interventions could preserve bone density without systemic drugs. However, the findings remain limited to mouse models, and human applicability is unproven. The October 16, 2026 publication date is noted as a placeholder in the source text.
What to watch: Human trials testing STING pathway modulation in bone health, and whether the DPP4-TLR4-STING interaction holds across species. Current evidence confirms the mechanism operates in mice but does not yet establish human relevance or therapeutic viability.
Source: Lifespan.io